Mediceo Paltac Holdings Co
Mediceo Paltac Holdings Co., a prominent player in the pharmaceutical preparation manufacturing industry, is headquartered in Japan. Established in 2004, the company has rapidly evolved, focusing on the development and distribution of high-quality pharmaceutical products. With a strong operational presence across various regions in Japan, Mediceo Paltac is dedicated to enhancing healthcare through innovative solutions.
The company’s core offerings include a diverse range of pharmaceutical preparations, which are distinguished by their commitment to quality and efficacy. Mediceo Paltac has achieved notable recognition within the industry, positioning itself as a trusted partner for healthcare providers. With a focus on research and development, the company continues to contribute significantly to the advancement of pharmaceutical manufacturing in Japan and beyond.
-10 vs industry average
Mediceo Paltac Holdings Co’s score of 28 is lower than 42% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Mediceo Paltac Holdings Co?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Mediceo Paltac Holdings Co's reported carbon emissions
Mediceo Paltac Holdings Co., headquartered in Japan and operating within the pharmaceutical preparation manufacturing sector, reported a total of 14.256 billion kg CO2e for fiscal year 2023. This figure encompasses Scope 1, Scope 2, and Scope 3 emissions, with Scope 3 accounting for the vast majority at approximately 14.130 billion kg CO2e.
For fiscal year 2024, the company reported Scope 1 and 2 emissions totalling approximately 73.575 million kg CO2e. In fiscal year 2022, Mediceo Paltac Holdings Co. disclosed Scope 1 emissions of approximately 30.194 million kg CO2e and Scope 2 emissions of approximately 45.890 million kg CO2e, with some Scope 3 emissions reported for upstream transportation and distribution.
In fiscal year 2021, the company reported Scope 1 emissions of approximately 32.573 million kg CO2e and Scope 2 emissions of approximately 49.959 million kg CO2e. Prior to this, for fiscal years 2018, 2019, and 2020, comprehensive emissions data was not disclosed.
Mediceo Paltac Holdings Co. has not disclosed any specific reduction targets or commitments to initiatives such as the Science Based Targets initiative (SBTi) or the Climate Pledge.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Mediceo Paltac Holdings Co’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Mediceo Paltac Holdings Co yet.
Scope 3 top emissions categories
11 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Mediceo Paltac Holdings Co
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project